Comparison of the pharmacological activity of idarubicin and doxorubicin for retinoblastoma

dc.creatorZugbi, Santiago
dc.creatorWinter, Ursula Andrea
dc.creatorCastañon, Agustina
dc.creatorSampor, Claudia
dc.creatorChantada, Guillermo Luis
dc.creatorSchaiquevich, Paula Susana
dc.date.accessioned2020-11-11T12:47:18Z
dc.date.accessioned2022-10-15T04:20:12Z
dc.date.available2020-11-11T12:47:18Z
dc.date.available2022-10-15T04:20:12Z
dc.date.created2020-11-11T12:47:18Z
dc.date.issued2019-01
dc.identifierZugbi, Santiago; Winter, Ursula Andrea; Castañon, Agustina; Sampor, Claudia; Chantada, Guillermo Luis; et al.; Comparison of the pharmacological activity of idarubicin and doxorubicin for retinoblastoma; Veterinary and Human Toxicology; Pediatric Blood & Cancer; 66; 1; 1-2019; 1-2
dc.identifier1545-5009
dc.identifierhttp://hdl.handle.net/11336/118117
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4344489
dc.languageeng
dc.publisherVeterinary and Human Toxicology
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1002/pbc.27441
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1002/pbc.27441
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectIDARUBICIN
dc.subjectDOXORUBICIN
dc.subjectRETINOBLASTOMA
dc.subjectCOMPARISON
dc.titleComparison of the pharmacological activity of idarubicin and doxorubicin for retinoblastoma
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución